https://sciencedaily.com/releases/2024/12/241209122554.htm
Researchers used lab-grown organoids created from tumors of individuals with glioblastoma (GBM) to accurately model a patient's response to CAR T cell therapy...
brain tumororganoidsmodelpatientresponse
https://www.biospace.com/press-releases/carsgen-therapeutics-introduced-zhuhai-sb-xinchuang-to-accelerate-allogeneic-car-t-cell-products-development-in-mainland-china
therapeuticsintroducedzhuhaisbaccelerate
https://blog.midipd.com/blog/the-beginnings-of-healthcares-next-iteration-innovations-in-rapid-diagnostics-post-pandemic-and-beyond-0-0-0
Advancements in research and technology have made possible a new treatment method that is highly targeted providing enhanced efficacy: CAR T-cell therapy.
a new eracancer treatmentdemocratization
https://www.cas.org/zh-hans/resources/cas-insights/car-t-cell-therapy
CAR-T cell therapy shows promising results in treating solid cancers, autoimmune diseases, HIV, and more
car t celltherapydrivesbreakthroughsmany
https://www.mdanderson.org/cancerwise/nurse-helps-cancer-patients-navigate-car-t-cell-therapy.h00-159545268.html
For clinical nurse Jeremiah Bergeron, caring for lymphoma and myeloma patients receiving CAR T cell therapy is a passion. Read what drives him.
car t cellmd andersonhelpingcancerpatients
https://www.thermofisher.com/blog/behindthebench/manufacturing-car-t-cell-therapies-challenges-insights-and-solutions/
Sep 9, 2024 - Since the first personalized cell therapy to treat advanced leukemia was approved by the US FDA in 2017, multiple CAR T cell therapies have been commercialized...
car t cellmanufacturingtherapieschallengesinsights
https://pubmed.ncbi.nlm.nih.gov/41349540/
Chimeric antigen receptor (CAR) T cell therapies targeting B cell maturation antigen (BCMA) are transforming treatment for relapsed or refractory multiple...
single celllongitudinalatlaspredictoutcome
https://www.ajmc.com/view/researchers-identify-potential-risk-factors-of-uncommon-thrombotic-events-following-car-t-cell-treatment
The study, wrote the researchers, offers insight into emerging and uncommon complications following chimeric antigen receptor (CAR) T-cell therapy.
risk factorsresearchersidentifypotentialuncommon
https://www.technologynetworks.com/biopharma/product-news/tc-biopharm-creates-allogeneic-cell-banks-for-car-t-cancer-therapy-products-314729
The first completed bio-banks will be used to develop more cost-effective, safe and efficacious cancer treatments.
tcbiopharmcreatesallogeneiccell